Antibody Production Market by Process (Upstream Processing, Downstream Processing, and Filtration), End-User (Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Research Institutes) - Global Forecast to 2021

Table of Contents

1 INTRODUCTION 21

1.1 OBJECTIVES OF THE STUDY 21
1.2 MARKET DEFINITION 21
1.3 MARKET SCOPE 22
1.3.1 MARKETS COVERED 22
1.3.2 YEARS CONSIDERED FOR THE STUDY 23
1.4 CURRENCY 23
1.5 LIMITATIONS 23
1.6 STAKEHOLDERS 23

2 RESEARCH METHODOLOGY 24

2.1 RESEARCH METHODOLOGY STEPS 24
2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 25
2.2.1 SECONDARY RESEARCH 25
2.2.1.1 Key data from secondary sources 25
2.2.2 PRIMARY RESEARCH 26
2.2.2.1 Key industry insights 27
2.2.2.2 Key data from primary sources 28
2.2.2.3 Key Insights from primary sources 29
2.3 MARKET SIZE ESTIMATION METHODOLOGY 29
2.4 MARKET FORECAST METHODOLOGY 31
2.5 MARKET DATA VALIDATION AND TRIANGULATION 32
2.6 ASSUMPTIONS FOR THE STUDY 32

3 EXECUTIVE SUMMARY 33

3.1 INTRODUCTION 33
3.2 CURRENT AND FUTURE SCENARIO 33
3.3 CONCLUSION 36

4 PREMIUM INSIGHTS 37

4.1 ANTIBODY PRODUCTION: MARKET OVERVIEW 37
4.2 ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2016 VS. 2021 38
4.3 ANTIBODY PRODUCTION MARKET SIZE, BY END USER, 2016 VS. 2021 39

5 MARKET OVERVIEW 40

5.1 INTRODUCTION 41
5.2 MARKET SEGMENTATION 41
5.3 MARKET DYNAMICS 42
5.3.1 DRIVERS 43
5.3.1.1 U.S. FDA clearance of therapeutic mAbs 43
5.3.1.2 Increasing adoption of targeted immunotherapy 44
5.3.1.3 Increasing R&D expenditure in pharmaceutical and biotechnological companies 44
5.3.1.4 Rising number of Fast Track and Orphan Drug designations 44
5.3.2 RESTRAINTS 45
5.3.2.1 Cost constraints related to the adoption of membrane filters 45
5.3.3 OPPORTUNITIES 46
5.3.3.1 Rising demand for protein therapeutics 46
5.3.3.2 Increasing risk of infectious diseases 46
5.3.3.3 Patent expiry of blockbuster mAbs 46
5.3.4 CHALLENGES 47
5.3.4.1 High costs of primary antibodies 47

6 ANTIBODY PRODUCTION MARKET, BY PROCESS 48

6.1 INTRODUCTION 49
6.2 UPSTREAM PROCESSING 50
6.2.1 BIOREACTORS 52
6.2.1.1 Large-scale bioreactors 55
6.2.1.2 Single-use bioreactors (SUBs) 57
6.2.2 CONSUMABLES 60
6.2.2.1 Media 62
6.2.2.2 Reagents and buffers 64
6.3 DOWNSTREAM PROCESSING 67
6.3.1 CHROMATOGRAPHY INSTRUMENTS 70
6.3.2 CHROMATOGRAPHY RESINS 73
6.3.2.1 Affinity Chromatography Resins 75
6.4 ION EXCHANGE (IEX) CHROMATOGRAPHY RESINS 78
6.5 HYDROPHOBIC INTERACTION CHROMATOGRAPHY (HIC) RESINS 81
6.6 MULTIMODAL CHROMATOGRAPHY RESINS 83
6.7 FILTRATION 86
6.7.1 FILTRATION SYSTEMS 88
6.7.2 FILTRATION CONSUMABLES AND ACCESSORIES 91

7 ANTIBODY PRODUCTION MARKET, BY END USER 94

7.1 INTRODUCTION 95
7.1.1 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 96
7.1.2 DIAGNOSTIC LABORATORIES 97
7.1.3 RESEARCH INSTITUTES 98

8 GLOBAL ANTIBODY PRODUCTION MARKET, BY REGION 99

8.1 INTRODUCTION 100
8.2 NORTH AMERICA 101
8.2.1 U.S. 106
8.2.1.1 Rising cancer incidence in the U.S. 106
8.2.1.2 Government funding for medical research 106
8.2.1.3 Conferences, symposia, and seminars on bioprocessing technologies 107
8.2.2 CANADA 110
8.2.2.1 Government initiatives to promote research 110
8.2.2.2 Need for quality cancer treatment 110
8.2.2.3 Regulatory approvals and authorization for use of mAbs 110
8.3 EUROPE 113
8.3.1 GERMANY 118
8.3.1.1 Increasing focus on R&D 118
8.3.1.2 Government funding 118
8.3.2 U.K. 121
8.3.2.1 Flourishing biotechnology and biopharmaceutical industry 121
8.3.3 FRANCE 124
8.3.3.1 Growing presence of chromatography players in France 124
8.3.4 REST OF EUROPE (ROE) 127
8.3.4.1 Investments and funding for life sciences to bolster the antibody production market 127
8.4 ASIA-PACIFIC 130
8.4.1 JAPAN 135
8.4.1.1 Growing biopharmaceutical sector and rise in geriatric population 135
8.4.2 CHINA 138
8.4.2.1 Increasing government and private-sector investments in China’s life sciences market 138
8.4.2.2 Outsourcing of clinical research activities to China 139
8.4.3 INDIA 142
8.4.3.1 Increasing government initiatives and growing pharmaceutical industry in India 142
8.4.3.2 Development of bioclusters to boost India’s biotechnology industry 142
8.4.4 REST OF ASIA-PACIFIC 146
8.4.4.1 Funding from the Australian government for scientific research and innovation 146
8.4.4.2 Infrastructural development in Vietnam 146
8.4.4.3 Rising pharmaceutical and biotechnology R&D activities in Korea 146
8.4.4.4 Government support for strong academic and commercial R&D activities in Taiwan 147
8.5 REST OF THE WORLD 150
8.5.1 LATIN AMERICA 155
8.5.1.1 Pharmaceutical, biotechnology, and research industries in Brazil to bolster the market 155
8.5.1.2 Mexico, the production hub for global pharmaceutical companies 155
8.5.2 MIDDLE EAST AND AFRICA (MEA) 158
8.5.2.1 Favorable business environment for pharmaceutical and biotechnology industries in Saudi Arabia and UAE 158
8.5.2.2 Increasing focus on Africa by pharmaceutical companies 159

9 COMPETITIVE LANDSCAPE 162

9.1 OVERVIEW 162
9.2 STRATEGIC OVERVIEW 162
9.3 COMPETITIVE SITUATION AND TRENDS 163
9.3.1 NEW PRODUCT LAUNCHES 164
9.3.2 EXPANSIONS 165
9.3.3 AGREEMENTS, ALLIANCES, PARTNERSHIPS, AND COLLABORATIONS 166
9.3.4 MERGERS AND ACQUISITIONS 168
9.3.5 OTHER STRATEGIES 169

10 COMPANY PROFILES 170

(Company at a Glance, Business Overview, Products Offered, Key Strategy, Recent Developments, SWOT Analysis & MNM View)*
10.1 INTRODUCTION 170
10.2 GE HEALTHCARE (A SUBSIDIARY OF GENERAL ELECTRIC COMPANY) 171
10.3 MERCK KGAA 175
10.4 THERMO FISHER SCIENTIFIC, INC. 178
10.5 SARTORIUS AG 182
10.6 PALL CORPORATION (ACQUIRED BY DANAHER CORPORATION) 186
10.7 SIGMA-ALDRICH CORPORATION (ACQUIRED BY MERCK KGAA) 188
10.8 EPPENDORF AG 191
10.9 CELLAB GMBH 194
10.10 INTEGRA BIOSCIENCES AG 195
10.11 FIBERCELL SYSTEMS INC. 197
*Details on company at a glance, recent financials, Products offered, strategies & insights, & recent developments might not be captured in case of unlisted companies.
11 APPENDIX 198

LIST OF TABLES

TABLE 1 INCREASING LIFE SCIENCE R&D EXPENDITURE IS PROPELLING THE GROWTH OF THE ANTIBODY PRODUCTION MARKET 45
TABLE 2 COST CONSTRAINTS RELATED TO THE ADOPTION OF MEMBRANE FILTERS TO RESTRAIN THE MARKET 45
TABLE 3 PATENT EXPIRY OF BLOCKBUSTER MABS OFFERS HUGE POTENTIAL FOR THE ANTIBODY PRODUCTION MARKET 47
TABLE 4 HIGH COSTS OF PRIMARY ANTIBODIES POSING AS A CHALLENGE FOR THE GROWTH OF THE ANTIBODY PRODUCTION MARKET 47
TABLE 5 ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014–2021 (USD MILLION) 49
TABLE 6 UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 50
TABLE 7 UPSTREAM PROCESSING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 50
TABLE 8 NORTH AMERICA: UPSTREAM PROCESSING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 51
TABLE 9 EUROPE: UPSTREAM PROCESSING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 51
TABLE 10 ASIA-PACIFIC: UPSTREAM PROCESSING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 52
TABLE 11 ROW: UPSTREAM PROCESSING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 52
TABLE 12 BIOREACTORS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 53
TABLE 13 BIOREACTORS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 53
TABLE 14 NORTH AMERICA: BIOREACTORS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 53
TABLE 15 EUROPE: BIOREACTORS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 54
TABLE 16 ASIA-PACIFIC: BIOREACTORS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 54
TABLE 17 ROW: BIOREACTORS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 54
TABLE 18 LARGE-SCALE BIOREACTORS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 55
TABLE 19 NORTH AMERICA: LARGE-SCALE BIOREACTORS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 55
TABLE 20 EUROPE: LARGE-SCALE BIOREACTORS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 56
TABLE 21 ASIA-PACIFIC: LARGE-SCALE BIOREACTORS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 56
TABLE 22 ROW: LARGE-SCALE BIOREACTORS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 57
TABLE 23 SINGLE-USE BIOREACTORS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 57
TABLE 24 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 58
TABLE 25 EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 58
TABLE 26 ASIA-PACIFIC: SINGLE-USE BIOREACTORS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 59
TABLE 27 ROW: SINGLE-USE BIOREACTORS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 59
TABLE 28 CONSUMABLES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 60
TABLE 29 CONSUMABLES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 60
TABLE 30 NORTH AMERICA: CONSUMABLES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 61
TABLE 31 EUROPE: CONSUMABLES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 61
TABLE 32 ASIA-PACIFIC: CONSUMABLES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 62
TABLE 33 ROW: CONSUMABLES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 62
TABLE 34 MEDIA MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 63
TABLE 35 NORTH AMERICA: MEDIA MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 63
TABLE 36 EUROPE: MEDIA MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 63
TABLE 37 ASIA-PACIFIC: MEDIA MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 64
TABLE 38 ROW: MEDIA MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 64
TABLE 39 REAGENTS AND BUFFERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 65
TABLE 40 NORTH AMERICA: REAGENTS AND BUFFERS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 65
TABLE 41 EUROPE: REAGENTS AND BUFFERS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 66
TABLE 42 ASIA-PACIFIC: REAGENTS AND BUFFERS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 66
TABLE 43 ROW: REAGENTS AND BUFFERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 67
TABLE 44 DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 67
TABLE 45 DOWNSTREAM PROCESSING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 68
TABLE 46 NORTH AMERICA: DOWNSTREAM PROCESSING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 68
TABLE 47 EUROPE: DOWNSTREAM PROCESSING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 69
TABLE 48 ASIA-PACIFIC: DOWNSTREAM PROCESSING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 69
TABLE 49 ROW: DOWNSTREAM PROCESSING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 70
TABLE 50 CHROMATOGRAPHY INSTRUMENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 70
TABLE 51 NORTH AMERICA: CHROMATOGRAPHY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 71
TABLE 52 EUROPE: CHROMATOGRAPHY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 71
TABLE 53 ASIA-PACIFIC: CHROMATOGRAPHY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 72
TABLE 54 ROW: CHROMATOGRAPHY INSTRUMENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 72
TABLE 55 CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014–2021 (USD MILLION) 73
TABLE 56 CHROMATOGRAPHY RESINS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 73
TABLE 57 NORTH AMERICA: CHROMATOGRAPHY RESINS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 74
TABLE 58 EUROPE: CHROMATOGRAPHY RESINS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 74
TABLE 59 ASIA-PACIFIC: CHROMATOGRAPHY RESINS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 75
TABLE 60 ROW: CHROMATOGRAPHY RESINS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 75
TABLE 61 AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 76
TABLE 62 NORTH AMERICA: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 76
TABLE 63 EUROPE: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 77
TABLE 64 ASIA-PACIFIC: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 77
TABLE 65 ROW: AFFINITY CHROMATOGRAPHY RESINS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 78
TABLE 66 IEX CHROMATOGRAPHY RESINS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 79
TABLE 67 NORTH AMERICA: IEX CHROMATOGRAPHY RESINS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 79
TABLE 68 EUROPE: IEX CHROMATOGRAPHY RESINS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 80
TABLE 69 ASIA-PACIFIC: IEX CHROMATOGRAPHY RESINS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 80
TABLE 70 ROW: IEX CHROMATOGRAPHY RESINS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 81
TABLE 71 HIC CHROMATOGRAPHY RESINS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 81
TABLE 72 NORTH AMERICA: HIC RESINS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 82
TABLE 73 EUROPE: HIC RESINS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 82
TABLE 74 ASIA-PACIFIC: HIC RESINS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 82
TABLE 75 ROW: HIC RESINS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 83
TABLE 76 MULTIMODAL CHROMATOGRAPHY RESINS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 83
TABLE 77 NORTH AMERICA: MULTIMODAL CHROMATOGRAPHY RESINS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 84
TABLE 78 EUROPE: MULTIMODAL CHROMATOGRAPHY RESINS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 84
TABLE 79 ASIA-PACIFIC: MULTIMODAL CHROMATOGRAPHY RESINS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 85
TABLE 80 ROW: MULTIMODAL CHROMATOGRAPHY RESINS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 85
TABLE 81 FILTRATION MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 86
TABLE 82 FILTRATION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 86
TABLE 83 NORTH AMERICA: FILTRATION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 87
TABLE 84 EUROPE: FILTRATION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 87
TABLE 85 ASIA-PACIFIC: FILTRATION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 87
TABLE 86 ROW: FILTRATION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 88
TABLE 87 FILTRATION SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 88
TABLE 88 NORTH AMERICA: FILTRATION SYSTEMS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 89
TABLE 89 EUROPE: FILTRATION SYSTEMS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 89
TABLE 90 ASIA-PACIFIC: FILTRATION SYSTEMS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 90
TABLE 91 ROW: FILTRATION SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 90
TABLE 92 FILTRATION CONSUMABLES AND ACCESSORIES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 91
TABLE 93 NORTH AMERICA: FILTRATION CONSUMABLES AND ACCESSORIES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 91
TABLE 94 EUROPE: FILTRATION CONSUMABLES AND ACCESSORIES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 92
TABLE 95 ASIA-PACIFIC: FILTRATION CONSUMABLES AND ACCESSORIES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 92
TABLE 96 ROW: FILTRATION CONSUMABLES AND ACCESSORIES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 93
TABLE 97 ANTIBODY PRODUCTION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION) 95
TABLE 98 ANTIBODY PRODUCTION MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2014–2021 (USD MILLION) 96
TABLE 99 ANTIBODY PRODUCTION MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY REGION, 2014–2021 (USD MILLION) 97
TABLE 100 ANTIBODY PRODUCTION MARKET SIZE FOR RESEARCH INSTITUTES, BY REGION, 2014–2021 (USD MILLION) 98
TABLE 101 ANTIBODY PRODUCTION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 101
TABLE 102 NORTH AMERICA: ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 103
TABLE 103 NORTH AMERICA: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014–2021 (USD MILLION) 103
TABLE 104 NORTH AMERICA: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 103
TABLE 105 NORTH AMERICA: BIOREACTORS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 104
TABLE 106 NORTH AMERICA: CONSUMABLES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 104
TABLE 107 NORTH AMERICA: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 104
TABLE 108 NORTH AMERICA: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014–2021 (USD MILLION) 105
TABLE 109 NORTH AMERICA: FILTRATION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 105
TABLE 110 U.S.: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014–2021 (USD MILLION) 107
TABLE 111 U.S.: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 108
TABLE 112 U.S.: BIOREACTORS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 108
TABLE 113 U.S.: CONSUMABLES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 108
TABLE 114 U.S.: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 109
TABLE 115 U.S.: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014–2021 (USD MILLION) 109
TABLE 116 U.S.: FILTRATION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 109
TABLE 117 CANADA: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014–2021 (USD MILLION) 111
TABLE 118 CANADA: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 111
TABLE 119 CANADA: BIOREACTORS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 111
TABLE 120 CANADA: CONSUMABLES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 112
TABLE 121 CANADA: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 112
TABLE 122 CANADA: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014–2021 (USD MILLION) 112
TABLE 123 CANADA: FILTRATION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 113
TABLE 124 EUROPE: ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 115
TABLE 125 EUROPE: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014–2021 (USD MILLION) 115
TABLE 126 EUROPE: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 116
TABLE 127 EUROPE: BIOREACTORS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 116
TABLE 128 EUROPE: CONSUMABLES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 116
TABLE 129 EUROPE: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 117
TABLE 130 EUROPE: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014–2021 (USD MILLION) 117
TABLE 131 EUROPE: FILTRATION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 117
TABLE 132 GERMANY: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014–2021 (USD MILLION) 119
TABLE 133 GERMANY: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 119
TABLE 134 GERMANY: BIOREACTORS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 119
TABLE 135 GERMANY: CONSUMABLES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 120
TABLE 136 GERMANY: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 120
TABLE 137 GERMANY: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014–2021 (USD MILLION) 120
TABLE 138 GERMANY: FILTRATION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 121
TABLE 139 U.K.: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014–2021 (USD MILLION) 122
TABLE 140 U.K.: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 122
TABLE 141 U.K.: BIOREACTORS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 122
TABLE 142 U.K.: CONSUMABLES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 123
TABLE 143 U.K.: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 123
TABLE 144 U.K.: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014–2021 (USD MILLION) 123
TABLE 145 U.K.: FILTRATION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 124
TABLE 146 FRANCE: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014–2021 (USD MILLION) 125
TABLE 147 FRANCE: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 125
TABLE 148 FRANCE: BIOREACTORS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 125
TABLE 149 FRANCE: CONSUMABLES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 126
TABLE 150 FRANCE: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 126
TABLE 151 FRANCE: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014–2021 (USD MILLION) 126
TABLE 152 FRANCE: FILTRATION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 127
TABLE 153 ROE: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014–2021 (USD MILLION) 128
TABLE 154 ROE: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 128
TABLE 155 ROE: BIOREACTORS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 128
TABLE 156 ROE: CONSUMABLES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 129
TABLE 157 ROE: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 129
TABLE 158 ROE: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014–2021 (USD MILLION) 129
TABLE 159 ROE: FILTRATION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 130
TABLE 160 ASIA-PACIFIC: ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 132
TABLE 161 ASIA-PACIFIC: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014–2021 (USD MILLION) 132
TABLE 162 ASIA-PACIFIC: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 133
TABLE 163 ASIA-PACIFIC: BIOREACTORS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 133
TABLE 164 ASIA-PACIFIC: CONSUMABLES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 133
TABLE 165 ASIA-PACIFIC: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 134
TABLE 166 ASIA-PACIFIC: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014–2021 (USD MILLION) 134
TABLE 167 ASIA-PACIFIC: FILTRATION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 134
TABLE 168 JAPAN: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014–2021 (USD MILLION) 136
TABLE 169 JAPAN: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 136
TABLE 170 JAPAN: BIOREACTORS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 136
TABLE 171 JAPAN: CONSUMABLES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 137
TABLE 172 JAPAN: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 137
TABLE 173 JAPAN: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014–2021 (USD MILLION) 137
TABLE 174 JAPAN: FILTRATION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 138
TABLE 175 CHINA: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014–2021 (USD MILLION) 139
TABLE 176 CHINA: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 140
TABLE 177 CHINA: BIOREACTORS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 140
TABLE 178 CHINA: CONSUMABLES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 140
TABLE 179 CHINA: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 141
TABLE 180 CHINA: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014–2021 (USD MILLION) 141
TABLE 181 CHINA: FILTRATION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 141
TABLE 182 INDIA: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014–2021 (USD MILLION) 143
TABLE 183 INDIA: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 143
TABLE 184 INDIA: BIOREACTORS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 144
TABLE 185 INDIA: CONSUMABLES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 144
TABLE 186 INDIA: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 144
TABLE 187 INDIA: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014–2021 (USD MILLION) 145
TABLE 188 INDIA: FILTRATION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 145
TABLE 189 ROAPAC: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014–2021 (USD MILLION) 147
TABLE 190 ROAPAC: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 148
TABLE 191 ROAPAC: BIOREACTORS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 148
TABLE 192 ROAPAC: CONSUMABLES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 148
TABLE 193 ROAPAC: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 149
TABLE 194 ROAPAC: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014–2021 (USD MILLION) 149
TABLE 195 ROAPAC: FILTRATION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 150
TABLE 196 ROW: ANTIBODY PRODUCTION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 152
TABLE 197 ROW: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014–2021 (USD MILLION) 152
TABLE 198 ROW: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 152
TABLE 199 ROW: BIOREACTORS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 153
TABLE 200 ROW: CONSUMABLES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 153
TABLE 201 ROW: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 153
TABLE 202 ROW: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014–2021 (USD MILLION) 154
TABLE 203 ROW: FILTRATION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 154
TABLE 204 LATIN AMERICA: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014–2021 (USD MILLION) 156
TABLE 205 LATIN AMERICA: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 156
TABLE 206 LATIN AMERICA: BIOREACTORS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 156
TABLE 207 LATIN AMERICA: CONSUMABLES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 157
TABLE 208 LATIN AMERICA: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 157
TABLE 209 LATIN AMERICA: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014–2021 (USD MILLION) 157
TABLE 210 LATIN AMERICA: FILTRATION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 158
TABLE 211 MEA: ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS, 2014–2021 (USD MILLION) 159
TABLE 212 MEA: UPSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 159
TABLE 213 MEA: BIOREACTORS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 160
TABLE 214 MEA: CONSUMABLES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 160
TABLE 215 MEA: DOWNSTREAM PROCESSING MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 160
TABLE 216 MEA: CHROMATOGRAPHY RESINS MARKET SIZE, BY TECHNIQUE, 2014–2021 (USD MILLION) 161
TABLE 217 MEA: FILTRATION MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 161
TABLE 218 NEW PRODUCT LAUNCHES (2013–2016) 164
TABLE 219 EXPANSIONS (2013–2016) 165
TABLE 220 AGREEMENTS, ALLIANCES, PARTNERSHIPS, AND COLLABORATIONS (2013–2016) 167
TABLE 222 OTHER STRATEGIES (2013–2016) 169

LIST OF FIGURES

FIGURE 1 GLOBAL ANTIBODY PRODUCTION MARKET SEGMENTATION 22
FIGURE 2 GLOBAL ANTIBODY PRODUCTION MARKET: RESEARCH METHODOLOGY STEPS 24
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 27
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 30
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 30
FIGURE 6 RESEARCH DESIGN 31
FIGURE 7 DATA TRIANGULATION METHODOLOGY 32
FIGURE 8 GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY PROCESS (2016 VS. 2021) 34
FIGURE 9 GLOBAL ANTIBODY PRODUCTION MARKET SIZE, BY END USER, 2016 VS. 2021 34
FIGURE 10 ASIA-PACIFIC MARKET TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 35
FIGURE 11 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE ANTIBODY PRODUCTION MARKET IN 2016 37
FIGURE 12 DOWNSTREAM PROCESSING SEGMENT TO WITNESS THE HIGHEST GROWTH RATE FROM 2016 TO 2021 38
FIGURE 13 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2021 39
FIGURE 14 ANTIBODY PRODUCTION MARKET SEGMENTATION 41
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES 42
FIGURE 16 APPROVALS OF THERAPEUTIC MONOCLONAL ANTIBODIES IN THE U.S. (1995-2015) 43
FIGURE 17 DOWNSTREAM PROCESSING TO COMMAND THE LARGEST SHARE OF THE ANTIBODY PRODUCTION MARKET, BY PROCESS 49
FIGURE 18 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES END-USER SEGMENT TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 95
FIGURE 19 ANTIBODY PRODUCTION MARKET, BY REGION, 2016 100
FIGURE 20 NORTH AMERICA: ANTIBODY PRODUCTION MARKET SNAPSHOT 102
FIGURE 21 EUROPE: ANTIBODY PRODUCTION MARKET SNAPSHOT 114
FIGURE 22 ASIA-PACIFIC: ANTIBODY PRODUCTION MARKET SNAPSHOT 131
FIGURE 23 ROW: ANTIBODY PRODUCTION MARKET SNAPSHOT 151
FIGURE 24 LEADING MARKET PLAYERS ADOPTED NEW PRODUCT LAUNCHES AS THEIR KEY GROWTH STRATEGY FROM 2013 TO 2016 162
FIGURE 25 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY ADOPTED BY MARKET PLAYERS (2013–2016) 163
FIGURE 26 NEW PRODUCT LAUNCHES, BY COMPANY (2013–2016) 164
FIGURE 27 EXPANSIONS, BY COMPANY (2013–2016) 165
FIGURE 28 AGREEMENTS, ALLIANCES, PARTNERSHIPS, AND COLLABORATIONS (2013–2016) 166
FIGURE 29 MERGER AND ACQUISITIONS, BY COMPANY (2013–2016) 168
FIGURE 30 OTHER STRATEGIES, BY COMPANY (2013–2016) 169
FIGURE 31 GEOGRAPHIC REVENUE MIX OF THE PROMINENT PLAYERS (2015) 170
FIGURE 32 GE HEALTHCARE: COMPANY SNAPSHOT 171
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT 175
FIGURE 34 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT 179
FIGURE 35 SARTORIUS AG: COMPANY SNAPSHOT 182
FIGURE 36 PALL CORPORATION: COMPANY SNAPSHOT 186
FIGURE 37 SIGMA-ALDRICH CORPORATION: COMPANY SNAPSHOT 188
FIGURE 38 EPPENDORF AG: COMPANY SNAPSHOT 191

当レポートのプレスリリースは発行されておりません。